SPK-8011QQ

PreclinicalSmall molecule

Roche

SPK-8011QQ is one of 51 small molecule programs targeting Hemophilia A. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hemophilia aRecruiting

Severe Hemophilia aActive, not recruiting

Hemophilia aPreclinical

Recruiting

Severe Hemophilia aPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

93 competitors in Hemophilia a

#DrugCompanyPhaseTrials

Hemlibra

Roche

Phase 3

16 2

Recombinant Human Coagulation FVIII

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3

2 3

Eptacog Alfa

Novo Nordisk

Phase 3

1 4

Qfitlia

GGenzyme, a Sanofi Company

Phase 3

1 5

Valoctocogene Roxaparvovec

BioMarin Pharmaceutical

Phase 3

3 6

Recombinant Factor VIII

Bayer

Phase 3

2 7

Translarna

PPTC Therapeutics

Phase 2

1 8

Rfviia

Roche

Phase 3

1 9

Marstacimab

Pfizer

Phase 3

1 10

PF-06741086

Pfizer

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2031

PreclinicalRecruiting

Hemophilia a

NCT07226206

Clinical

Trials by Indication[1]

Hemophilia A1 trial

A Phase 2b, Single-Arm, Open-Label, Multicenter Study of the Safety of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Recruiting· Roche logo

Roche·Preclinical·NCT07226206·5 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for SPK-8011QQ. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — SPK-8011QQ compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for SPK-8011QQ. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Roche company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Roche

SPK-8011QQ

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2031

Trials by Indication[1]

Hemophilia A1 trial

References

Drug Info

Quick Facts

Related News